What Researchers Did
Researchers investigated the effectiveness of hyperbaric oxygen therapy alongside surgery and antibiotics for severe necrotizing infections, also exploring methods to measure tissue gas tensions.
What They Found
Among 53 patients with Clostridial gas gangrene treated with hyperbaric oxygen therapy (2.5 ATA), surgery, and antibiotics, the mortality rate was 22.6% (12 patients died). The study suggested that hyperbaric oxygen therapy helps save lives, limbs, and tissue in gas gangrene, emphasizing the importance of early diagnosis for improved survival.
What This Means for Canadian Patients
Canadian patients diagnosed with severe necrotizing infections, such as gas gangrene, may experience improved outcomes when hyperbaric oxygen therapy is integrated into their treatment. This approach, combined with early diagnosis, surgery, and antibiotics, could enhance survival rates and help preserve affected limbs and tissues.
Canadian Relevance
This study covers gas gangrene and necrotizing fasciitis, both of which are Health Canada-recognized indications for hyperbaric oxygen therapy. While the study itself was conducted in Finland, its findings are relevant to Canadian clinical practice.
Study Limitations
A limitation of the human patient data is the observational nature and lack of a direct control group, making it challenging to isolate the specific impact of hyperbaric oxygen therapy.